Accessibility Menu
 
InflaRx logo

InflaRx

(NASDAQ) IFRX

Current Price$2.40
Market Cap$182.18M
Since IPO (2017)-83%
5 Year-15%
1 Year+29%
1 Month+109%

InflaRx Financials at a Glance

Market Cap

$182.18M

Revenue (TTM)

$28.17K

Net Income (TTM)

$41.20M

EPS (TTM)

$0.00

P/E Ratio

-2.41

Dividend

$0.00

Beta (Volatility)

0.91 (Low)

Price

$2.40

Volume

19,651

Open

$2.50

Previous Close

$2.40

Daily Range

$2.39 - $2.60

52-Week Range

$0.71 - $2.95

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About InflaRx

Industry

Biotechnology

Employees

65

CEO

Niels Christoph Riedemann, MD, PhD

Headquarters

Jena, 07745, DE

IFRX Financials

Key Financial Metrics (TTM)

Gross Margin

-264%

Operating Margin

-1522%

Net Income Margin

-1463%

Return on Equity

0%

Return on Capital

-1%

Return on Assets

-84%

Earnings Yield

-41.49%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$182.18M

Shares Outstanding

72.29M

Volume

19.65K

Avg. Volume

1.45M

Financials (TTM)

Gross Profit

$7.36M

Operating Income

$48.91M

EBITDA

$48.50M

Operating Cash Flow

$33.92M

Capital Expenditure

$111.13K

Free Cash Flow

$34.03M

Cash & ST Invst.

$46.44M

Total Debt

$897.53K

InflaRx Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$88.61K

-853.8%

Gross Margin

0.00%

N/A

Market Cap

$182.18M

N/A

Market Cap/Employee

$2.46M

N/A

Employees

74

N/A

Net Income

$5.68M

+31.6%

EBITDA

$6.88M

+16.1%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$39.02M

-40.1%

Accounts Receivable

$1.65M

-2.4%

Inventory

$0.00

-100.0%

Long Term Debt

$572.33K

+93.7%

Short Term Debt

$251.55K

-38.2%

Return on Assets

-84.19%

N/A

Return on Invested Capital

-1.14%

N/A

Free Cash Flow

$7.52M

+46.4%

Operating Cash Flow

$7.51M

+46.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CNTXContext Therapeutics Inc.
$2.33-1.27%
CNTBConnect Biopharma Holdings Limited
$2.48+1.22%
ARTVArtiva Biotherapeutics, Inc.
$10.68+1.71%
KLRSKalaris Therapeutics Inc
$5.22+8.07%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$11.21+0.27%
FFord Motor Company
$14.48+0.07%
AIIORobo.ai
$5.64+1.16%
NOKNokia
$14.46-0.02%

Questions About IFRX

What is the current price of InflaRx?

InflaRx is trading at $2.40 per share.

What is the 52-week range for InflaRx?

Over the past 52 weeks, InflaRx has traded between $0.71 and $2.95.

How much debt does InflaRx have?

As of the most recent reporting period, InflaRx reported total debt of $948,292.862.

How much cash does InflaRx have on hand?

InflaRx reported $17.28M in cash and cash equivalents in its most recent financial results.

What is InflaRx’s dividend yield?

InflaRx does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.